ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone510-279-4262
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees162
Next Earnings Date11/7/2019 (Confirmed)
OptionableNot Optionable
Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions
What is Shockwave Medical's stock symbol?
Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."
How were Shockwave Medical's earnings last quarter?
Shockwave Medical Inc (NASDAQ:SWAV) issued its earnings results on Monday, August, 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.55) by $0.17. The business earned $10 million during the quarter, compared to the consensus estimate of $8.29 million. Shockwave Medical's quarterly revenue was up 334.8% compared to the same quarter last year. View Shockwave Medical's Earnings History.
When is Shockwave Medical's next earnings date?
How can I listen to Shockwave Medical's earnings call?
Shockwave Medical will be holding an earnings conference call on Thursday, November 7th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Shockwave Medical issued on next quarter's earnings?
Shockwave Medical updated its FY 2019 earnings guidance on Monday, August, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $38-40 million, compared to the consensus revenue estimate of $35.39 million.
What price target have analysts set for SWAV?
5 equities research analysts have issued 1-year target prices for Shockwave Medical's stock. Their predictions range from $32.00 to $65.00. On average, they anticipate Shockwave Medical's stock price to reach $42.60 in the next twelve months. This suggests a possible upside of 25.4% from the stock's current price. View Analyst Price Targets for Shockwave Medical.
What is the consensus analysts' recommendation for Shockwave Medical?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Shockwave Medical.
Has Shockwave Medical been receiving favorable news coverage?
Media coverage about SWAV stock has been trending extremely negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Shockwave Medical earned a news impact score of -4.6 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Shockwave Medical.
Are investors shorting Shockwave Medical?
Shockwave Medical saw a decrease in short interest in the month of September. As of September 15th, there was short interest totalling 2,140,000 shares, a decrease of 22.7% from the August 15th total of 2,770,000 shares. Based on an average daily volume of 425,600 shares, the days-to-cover ratio is presently 5.0 days. Currently, 11.7% of the company's shares are sold short. View Shockwave Medical's Current Options Chain.
Who are some of Shockwave Medical's key competitors?
Some companies that are related to Shockwave Medical include NuVasive (NUVA), ICU Medical (ICUI), Cantel Medical (CMD), Nevro (NVRO), Glaukos (GKOS), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Cardiovascular Systems (CSII), Atrion (ATRI), Inspire Medical Systems (INSP), AtriCure (ATRC), Silk Road Medical (SILK), Orthofix Medical (OFIX), Tactile Systems Technology (TCMD) and Luminex (LMNX).
What other stocks do shareholders of Shockwave Medical own?
Who are Shockwave Medical's key executives?
Shockwave Medical's management team includes the folowing people:
- Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
- Mr. Daniel Puckett, CFO & Sec. (Age 55)
- Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
- Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
- Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)
When did Shockwave Medical IPO?
(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
When did Shockwave Medical's lock-up period expire?
Shockwave Medical's lock-up period expired on Tuesday, September 3rd. Shockwave Medical had issued 5,700,000 shares in its IPO on March 7th. The total size of the offering was $96,900,000 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.
Who are Shockwave Medical's major shareholders?
Shockwave Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Capital Investment Advisory Services LLC (0.02%) and Wealthcare Advisory Partners LLC (0.00%). Company insiders that own Shockwave Medical stock include Antoine Papiernik, Dan Puckett, Frederic H Moll, Isaac Zacharias and James E Flynn. View Institutional Ownership Trends for Shockwave Medical.
Which institutional investors are buying Shockwave Medical stock?
How do I buy shares of Shockwave Medical?
Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Shockwave Medical's stock price today?
One share of SWAV stock can currently be purchased for approximately $33.98.
How big of a company is Shockwave Medical?
What is Shockwave Medical's official website?
How can I contact Shockwave Medical?
Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]
MarketBeat Community Rating for Shockwave Medical (NASDAQ SWAV)
MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote "Outperform" if you believe SWAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
